Skip to main content
HLB Pep Co., Ltd. logo

HLB Pep Co., Ltd. — Investor Relations & Filings

Ticker · 196300 ISIN · KR7196300008 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2026-03-10 Earnings Release
Country KR South Korea
Listing KO 196300

About HLB Pep Co., Ltd.

http://hlbpep.co.kr/eng/main/

HLB Pep Co., Ltd. is a biopharmaceutical company specializing in the research, development, and production of peptide-based biomaterials and new drugs. The company's core activities include the manufacturing of peptide Active Pharmaceutical Ingredients (APIs) in a GMP-certified facility. It offers a range of products and services, including generic peptides, custom peptide synthesis for research and development, and a catalog of approximately 1,000 research peptides such as hormones and neuropeptides. HLB Pep focuses on discovering new drug candidates and aims to commercialize them through technology transfer.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변동
Earnings Release Classification · 95% confidence The document is a regulatory filing from a Korean company (HLB PEP) regarding a significant change in financial results (30% or more variance in revenue or profit). This is a standard 'Earnings Release' or 'Preliminary Financial Results' filing required by the Korea Exchange (KRX) when financial performance deviates significantly from the previous period. It provides key financial highlights (revenue, operating profit, net income) and explicitly states that these are preliminary figures subject to audit, which is characteristic of an Earnings Release (ER). FY 2025
2026-03-10 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) for HLB PEP. It outlines the date, time, location, and the specific agenda items (such as financial statement approval, articles of incorporation changes, and director compensation limits) to be voted on at the upcoming meeting. This is a standard proxy solicitation document used to inform shareholders of an upcoming meeting and the matters to be decided, which falls under the Proxy Solicitation & Information Statement category.
2026-03-10 Korean
신규시설투자등
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from HLB regarding a 'New Facility Investment' (신규시설투자등). It details the investment amount, purpose (headquarters relocation and production facility expansion), investment period, and board approval details. Since this is a specific corporate announcement regarding capital expenditure and facility investment that does not fit into the other specific categories like M&A or share issues, it is classified as a general regulatory filing.
2026-02-13 Korean
전환가액의조정 (제3회차)
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory filing regarding the adjustment of the conversion price for convertible bonds (제3회차). It details the change in conversion price, the number of convertible shares, and the methodology used for the adjustment based on market price fluctuations. This type of disclosure is a standard corporate action related to capital structure and financing instruments, which falls under the 'Capital/Financing Update' category.
2026-01-08 Korean
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sales/Supply Contract' (단일판매ㆍ공급계약체결) filed by HLB Pep. It details the contract value, counterparty, duration, and payment terms. Since this is a specific regulatory announcement of a material business event (a supply contract) that does not fit into categories like financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2026-01-02 Korean
대표이사변경
Board/Management Information Classification · 100% confidence The document is a formal announcement regarding a change in the company's representative director (CEO). It details the transition from a co-CEO structure to a sole CEO structure, provides the reason for the change (resignation), and includes biographical information and career history for the remaining CEO. This falls directly under the category of Board/Management Information.
2026-01-02 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.